Famotidine Powder, For Suspension
Product Images NDC 68382-444

2 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 68382-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Afe82389 1a91 441a A13a B673983b317b 207 1)

Image (Afe82389 1a91 441a A13a B673983b317b 207 1)
Chemical structure of famotidine, the active ingredient in FAMOTIDINE powder for suspension 40 mg/5 mL by Zydus Pharmaceuticals USA Inc.*
FDA Label Image

Figure (Afe82389 1a91 441a A13a B673983b317b 01)

Figure (Afe82389 1a91 441a A13a B673983b317b 01)
Label for FAMOTIDINE for Oral Suspension USP 40 mg/5 mL powder for suspension by Zydus Pharmaceuticals USA Inc. The label indicates the product contains 400 mg of famotidine in a constituted 50 mL bottle, with each 5 mL dose containing 40 mg. The label includes a barcode, storage instructions, inactive ingredients, directions for constitution, and a caution to shake well before use. The product is Rx only and not for injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.